Evidence map›Paper›PMID 34359565›Full record

ArticleCancers2021

BRCA2 Promotes Spontaneous Homologous Recombination In Vivo.

Adam D Brown, Scott Greenman, Alison B Claybon, Alexander J R Bishop

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Adam D BrownDepartment of Cellular Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Scott GreenmanDepartment of Exercise Sciences, Brigham Young University, Provo, UT 84602, USA.
Alison B ClaybonGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Alexander J R BishopDepartment of Cellular Systems and Anatomy, University of Texas Health San Antonio, San Antonio, TX 78229, USA.ORCID 0000-0002-5742-4387
The University of Texas Health Science Center at San Antonio · USBrigham Young University · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
TRAINING GRANT ON THE BIOLOGY OF AGINGT32AG021890 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Erzsebet Kokovay, JAMES FLOYD NELSON · 2003 to 2026
$11.4M
A screen for damage response genes using recombinationK22ES012264 · NIEHS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BISHOP, ALEXANDER JAMES · 2004 to 2006
$321k
American Cancer Society ACS-IRG-00-173-04National Institute of Aging T32AG021890NCI NIH HHS P30 CA054174NCI NIH HHS P30CA054174NIEHS NIH HHS K22 ES012264NIEHS NIH HHS K22ES012264
6 · The paper itself

Abstract

backgroundBRCA2 is known to be a tumor suppressor involved in homologous recombination repair and presumed to prevent genome instability in normal tissues prior to the development of tumors. Typical assessment of BRCA2 deficiency on the genome involves cell-based models using cancer cells with mixed genetic contexts, but the role in normal tissue in vivo has not been clearly demonstrated.

methodsUsing conditional deletion of

resultsIn the current study, we show that conditional loss of

conclusionsTherefore, our results demonstrate that BRCA2, as expected, is required for high-fidelity homologous recombination DNA repair in normal tissues, here in a tissue undergoing normal proliferation through normal development.

Indexed as

BRCA2homologous recombinationmousepink-eyed unstable

Identifiers

PMID34359565
PMCPMC8345144
OpenAlexW3185416049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.